Company intelligence / Profile preview

Mubadala Capital

Abu Dhabi, Abu Dhabi, United Arab Emiratesmubadalacapital.ae ↗

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Mubadala Capital is the alternative asset management subsidiary of Mubadala Investment Company, managing over $27–30 billion in assets across private equity, venture capital, and other strategies. It invests globally with a significant focus on healthcare and life sciences through its venture arm. The firm has backed about 45 life sciences companies as of 2024[6][8].

Therapeutic areas: OncologyMultiple
Modalities: Small moleculeBiologicsGene therapyRNA-based therapiesRegenerative medicine
Industry: Investors

Partnerships

Co-investments with major VCs and pharma investors such as AbbVie Ventures, Bristol Myers Squibb, Taiho Ventures, Versant VenturesPartnerships with LaunchBio/Browne Consulting/Silicon Valley Bank for deal sourcing events targeting biotech startups

Beyond the preview

Go deeper on Mubadala Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mubadala Capital.

Explore the full profile